1 Min Read
Jan 3 (Reuters) - Shire Plc:
* XIIDRA APPROVED BY HEALTH CANADA TO TREAT SIGNS AND SYMPTOMS OF DRY EYE DISEASE
* XIIDRA WILL BE AVAILABLE FOR PATIENTS IN CANADA IN EARLY 2018. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.